EUVIMEDSkopri EUVIMED
Video/AudioOpen access

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids

Olivia Graham, Jeimmy Rodriguez, Lillian van Biljon, Bisiayo Fashemi, Emily Graham, Katherine Fuh, Dineo Khabele, Mary Mullen

Journal of Visualized Experiments · 2023

DOI: 10.3791/64878 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2023. Written by Olivia Graham and 7 co-authors. Institution: Washington University in St. Louis. Major MEDLINE topics: Ovarian Neoplasms, Cystadenocarcinoma, Serous. Cited 7 times so far (Crossref); 19 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Organoids are 3D dynamic tumor models that can be grown successfully from patient-derived ovarian tumor tissue, ascites, or pleural fluid and aid in the discovery of novel therapeutics and predictive biomarkers for ovarian cancer. These models recapitulate clonal heterogeneity, the tumor microenvironment, and cell-cell and cell-matrix interactions. Additionally, they have been shown to match the primary tumor morphologically, cytologically, immunohistochemically, and genetically. Thus, organoids facilitate research on tumor cells and the tumor microenvironment and are superior to cell lines. The present protocol describes distinct methods to generate patient-derived ovarian cancer organoids from patient tumors, ascites, and pleural fluid samples with a higher than 97% success rate. The patient samples are separated into cellular suspensions by both mechanical and enzymatic digestion. The cells are then plated utilizing a basement membrane extract (BME) and are supported with optimized growth media containing supplements specific to the culturing of high-grade serous ovarian cancer (HGSOC). After forming initial organoids, the PDOs can sustain long-term culture, including passaging for expansion for subsequent experiments.

Subjects

MeSH terms (MEDLINE)

Ovarian NeoplasmsCystadenocarcinoma, SerousHumansFemaleAscitesCarcinoma, Ovarian EpithelialOrganoidsTumor Microenvironment

Authors and institutions

  • Washington University in St. Louis.
  • Washington University in St. Louis; University of California San Francisco.
  • Washington University in St. Louis; marymullen@wustl.edu.

Funding

  • NCI NIH HHS

Cite

APA

Graham, O., Rodriguez, J., van Biljon, L., Fashemi, B., Graham, E., Fuh, K., Khabele, D., & Mullen, M. (2023). Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids. Journal of Visualized Experiments. https://doi.org/10.3791/64878

Vancouver

Graham O, Rodriguez J, van Biljon L, Fashemi B, Graham E, Fuh K, et al. Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids. Journal of Visualized Experiments. 2023. doi:10.3791/64878

BibTeX
@article{Graham2023,
  author = {Graham, Olivia and Rodriguez, Jeimmy and van Biljon, Lillian and Fashemi, Bisiayo and Graham, Emily and Fuh, Katherine and Khabele, Dineo and Mullen, Mary},
  title = {Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids},
  journal = {Journal of Visualized Experiments},
  year = {2023},
  doi = {10.3791/64878}
}
Start for free →